A detailed history of Bessemer Group Inc transactions in Zoetis Inc. stock. As of the latest transaction made, Bessemer Group Inc holds 31,117 shares of ZTS stock, worth $5.12 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
31,117
Previous 31,155 0.12%
Holding current value
$5.12 Million
Previous $5.4 Million 12.57%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$172.58 - $196.48 $6,558 - $7,466
-38 Reduced 0.12%
31,117 $6.08 Million
Q2 2024

Aug 13, 2024

SELL
$145.54 - $178.83 $1.75 Million - $2.16 Million
-12,054 Reduced 27.9%
31,155 $5.4 Million
Q1 2024

May 13, 2024

SELL
$165.67 - $199.94 $69.6 Million - $84 Million
-420,130 Reduced 90.67%
43,209 $7.31 Million
Q4 2023

Feb 09, 2024

SELL
$151.44 - $200.09 $780,067 - $1.03 Million
-5,151 Reduced 1.1%
463,339 $91.5 Million
Q3 2023

Nov 13, 2023

SELL
$167.14 - $192.77 $1.62 Million - $1.87 Million
-9,701 Reduced 2.03%
468,490 $81.5 Million
Q2 2023

Aug 10, 2023

SELL
$160.94 - $186.23 $114 Million - $131 Million
-706,043 Reduced 59.62%
478,191 $82.3 Million
Q1 2023

May 10, 2023

SELL
$145.48 - $175.02 $91.3 Million - $110 Million
-627,434 Reduced 34.63%
1,184,234 $197 Million
Q4 2022

Feb 13, 2023

SELL
$131.14 - $157.47 $26.8 Million - $32.2 Million
-204,321 Reduced 10.14%
1,811,668 $265 Million
Q3 2022

Nov 09, 2022

SELL
$148.29 - $182.55 $1.17 Million - $1.44 Million
-7,892 Reduced 0.39%
2,015,989 $299 Million
Q2 2022

Aug 10, 2022

SELL
$155.97 - $200.09 $674,882 - $865,789
-4,327 Reduced 0.21%
2,023,881 $348 Million
Q1 2022

May 12, 2022

BUY
$181.39 - $234.03 $4.69 Million - $6.05 Million
25,850 Added 1.29%
2,028,208 $382 Million
Q4 2021

Jan 27, 2022

BUY
$193.69 - $247.03 $37.6 Million - $48 Million
194,242 Added 10.74%
2,002,358 $489 Million
Q3 2021

Nov 12, 2021

BUY
$189.29 - $209.69 $43.3 Million - $48 Million
228,807 Added 14.49%
1,808,116 $351 Million
Q2 2021

Aug 06, 2021

BUY
$155.9 - $187.99 $985,443 - $1.19 Million
6,321 Added 0.4%
1,579,309 $294 Million
Q1 2021

May 13, 2021

BUY
$144.0 - $169.39 $4.67 Million - $5.5 Million
32,451 Added 2.11%
1,572,988 $248 Million
Q4 2020

Feb 09, 2021

SELL
$157.07 - $174.35 $147,174 - $163,365
-937 Reduced 0.06%
1,540,537 $255 Million
Q3 2020

Nov 12, 2020

SELL
$137.1 - $165.37 $52 Million - $62.7 Million
-379,067 Reduced 19.74%
1,541,474 $255 Million
Q2 2020

Aug 05, 2020

BUY
$111.92 - $142.53 $3 Million - $3.82 Million
26,795 Added 1.41%
1,920,541 $263 Million
Q1 2020

Apr 30, 2020

BUY
$92.66 - $144.94 $3.15 Million - $4.93 Million
34,047 Added 1.83%
1,893,746 $223 Million
Q4 2019

Feb 04, 2020

SELL
$116.25 - $133.25 $1.62 Million - $1.85 Million
-13,903 Reduced 0.74%
1,859,699 $246 Million
Q3 2019

Nov 07, 2019

SELL
$112.57 - $128.43 $119 Million - $136 Million
-1,056,742 Reduced 36.06%
1,873,602 $233 Million
Q2 2019

Jul 19, 2019

SELL
$97.98 - $114.28 $2.17 Million - $2.53 Million
-22,113 Reduced 0.75%
2,930,344 $333 Million
Q1 2019

May 13, 2019

SELL
$81.56 - $100.67 $2.45 Million - $3.02 Million
-29,994 Reduced 1.01%
2,952,457 $297 Million
Q4 2018

Feb 12, 2019

SELL
$79.28 - $95.27 $40.1 Million - $48.2 Million
-505,644 Reduced 14.5%
2,982,451 $255 Million
Q3 2018

Nov 06, 2018

BUY
$83.5 - $93.23 $2.39 Million - $2.67 Million
28,598 Added 0.83%
3,488,095 $319 Million
Q2 2018

Jul 25, 2018

BUY
$79.9 - $89.2 $1.21 Million - $1.35 Million
15,112 Added 0.44%
3,459,497 $295 Million
Q1 2018

May 10, 2018

BUY
$71.51 - $84.69 $94.9 Million - $112 Million
1,326,731 Added 62.65%
3,444,385 $288 Million
Q4 2017

Jan 30, 2018

BUY
$63.24 - $72.8 $134 Million - $154 Million
2,116,740 Added 231590.81%
2,117,654 $153 Million
Q3 2017

Nov 03, 2017

BUY
$59.73 - $65.4 $54,593 - $59,775
914
914 $58,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $77.1B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Bessemer Group Inc Portfolio

Follow Bessemer Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.